Позитронная эмиссионная томография в диагностике и выборе тактики лечения немелкоклеточного рака легких
Диссертация
Исследование возможностей ПЭТ в диагностике HMPJI является одной из наиболее изучаемых проблем клинической онкологии (W.R. Webb et al., 1991; C.S. Brock et al., 1997; H. Zhuang et al., 2001; C.B. Ширяев, 2001; T.M. Blodjett et al., 2007). По данным современной литературы, большинством авторов позитронно-эмиссионная томография признается наиболее достоверным методом в оценке распространенности… Читать ещё >
Содержание
- ГЛАВА I. Современные представления о диагностике и лечении немелкоклеточного рака легкого (обзор литературы)
- 1. 1. Актуальность проблемы
- 1. 2. Стадирование немелкоклеточного рака легкого
- 1. 3. Современные представления о выборе тактики лечения НМРЛ
- 1. 4. Современные аспекты диагностики рака легкого
- 1. 5. Позитронная эмиссионная томография при НМРЛ
- 1. 5. 1. Общие сведения. История развития метода
- 1. 5. 2. Физиологические основы ФДГ ПЭТ
- 1. 5. 3. Роль ПЭТ в оценке первичного очага при НМРЛ
- 1. 5. 4. Возможности метода в оценке состояния лимфатических узлов
- 1. 5. 5. Выявление генерализации опухолевого процесса при ПЭТ
- 1. 5. 6. Влияние результатов ПЭТ на выбор тактики больных НМРЛ
- 2. 1. Характеристика больных. Распределение по группам
- 2. 2. Методы обследования больных НМРЛ
- 2. 2. 1. Стандартные методы обследования больных
- 2. 2. 2. Методика ПЭТ-исследования
- 2. 3. Статистическая обработка полученных данных
- 3. 1. ПЭТ в оценке первичного очага при НМРЛ и дифференциальной диагностике очаговых образований в легких
- 3. 2. Позитронная эмиссионная томография в диагностике состояния регионарных лимфоузлов при НМРЛ
- 3. 3. Позитронная эмиссионная томография в стадировании немелкоклеточного рака легкого
- 3. 4. Влияние данных позитронной эмиссионной томографии на выбор тактики лечения
- 3. 5. Лечебно-диагностический алгоритм при немелкоклеточном раке легкого
Список литературы
- Аллахвердиев А.К. " Расширенные операции в хирургическом лечении рака легкого" Автореф. Дисс. Канд. Мед. наук-2003.
- Барчук A.C. Стандарты лечения немелкоклеточного рака легкого// Вестник Российского Онкологического Научного Центра им H.H. Бло-хина -№ 1−2003- стр. 3−7
- Бычков М.Б. Химиотерапия распространенного немелкоклеточного рака легкого// Вестник Российского Онкологического Научного Центра им H.H. Блохина -№ 1−2003- стр.8−13
- Гранов A.M., Тютин Л. А., Костеников H.A. и соавторы. ПЭТ в онкологической клинике. // Материалы российского Онкологического конгресса. 2006.
- Давыдов М.И., Полоцкий Б. Е. Рак легкого— М.:Радикс, 1994- 210с.
- Корсаков М.В. Руководство по ПЭТ-химии.-СПб.:ТЕЗА, 2002−180с.
- Куренков В.Г., Фадеев Н. П. Позитронная эмиссионная томогра-фия(физико-химические аспекты)// Мед.радиол. 1986,31 ,№ 10,6−76с.
- Лактионов К.К.// Автореферат дисс. Докт. Наук-2005.
- Лукьянченко А.Б., Полоцкий Б. Е., В.А.Гальченко, Алексеева Т. Р. Современные тенденции в лучевой диагностике немелкоклеточного рака легкого// Вестник Российского Онкологического Научного Центра им H.H. Блохина -№ 1−2003- стр.29−32.
- Ю.Мерабишвили В. М. Статистика рака легкого (заболеваемость, смертность, выживаемость)// Практическая онкология- № 3−2000.
- Наркевич Б.Я. Однофотонная эмиссионная компьютерная томография с позитронно-излучающими радиофармпрепаратами: современное состояние и направление развития// Мед.радиол. и радиац. безопасность, 2000, 45,№ 6, 56−63с.
- Наркевич Б .Я., Костылев В. А. Физические основы ядерной медици-ны.-М.:АМФ-пресс, 2001−60с.
- Орлова C.B. Современное стандартное лечение больных немелкокле-точным раком легкого с учетом стадии заболевания// Практическая онкология- № 3−2000.
- Стилиди И.С. Тер-Ованесов М.Д.Хирургическое лечение рака легкого. // Практическая онкология- № 3−2000.
- Трахтенберг А.Х., Франк Г. А., Колбанов К. И., Стукалов М. А. Комбинированные операции при немелкоклеточном раке легкого III стадии// Вестник Российского Онкологического Научного Центра им H.H. Блохина -№ 1−2003- стр.50−55.
- Тюляндин С.А., Полоцкий Б. Е. Тактика лечения немелкоклеточного рака легкого III стадии. Практическая онкология № 27- 2006
- Хмелев A.B., Ширяев C.B., Костылев В. А. Позитронная Эмиссионная Томография. -М: АМФ-пресс, 2004−5с
- Ширяев C.B. Ядерная медицина в диагностике и лечении онкологических заболеваний//Мат.Евр. школы онк., г. Москва- 2001
- Adler L.P., Blair H.F., Makley J.T. et al. Comparison of PET with CT, MRI, and conventional scintigraphy in a benign and in a malignant soft tissue tumor.//Orthopedics. 1991 — Vol. 14. — № 8. — P. 891 — 894.
- Akhurst T. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.// J Surg Oncol. 2006.
- Annette Fritscher-Ravens., Bruce L. Davidson., Hans-Peter Hauber., et al. Endoscopic Ultrasound, Positron Emission Tomography and Computerized Tomography for Lung Cancer.// Am J of Respir Crit Care. 2003. — Vol. 168. — P. 1293−1297
- Aquino S.L., Fischman A.J. Does whole-body 2-18 °F.-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer? //Chest. 2004. — Vol. 126. № 3.- P. 755 — 760.
- Arita T. Bronchogenic carcinoma: incidence of metastasis to normal sized lymph nodes// Thorax.-1995. Vol.50. — P. 1267−1269
- Bastarrilca G., Garcia-Velloso MJ., Lozano MD. Early lung cancer detection using spiral computed tomography and positron emission tomography.// Am J Respir Crit Care Med.-2005- Vol. 171.-№ 12.-P. 1378−83.
- Adler L.P., Blair H.F., Makley J.T. et al. Comparison of PET with CT, MRI, and conventional scintigraphy in a benign and in a malignant soft tissue tumor.//Orthopedics. 1991 — Vol. 14. — № 8. — P. 891 — 894.
- Akhurst T. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum, glucose and prediction of nodal status in non-small cell lung cancer.// J Surg Oncol. 2006.
- Annette Fritscher-Ravens., Bruce L. Davidson., Hans-Peter Hauber., et al. Endoscopic Ultrasound, Positron Emission Tomography and Computerized Tomography for Lung Cancer.// Am J of Respir Crit Care. 2003. — Vol. 168.-P. 1293−1297
- Aquino S.L., Fischman A.J. Does whole-body 2-18 °F.-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer? //Chest. 2004. — Vol. 126. № 3.- P. 755 — 760.
- Arita T. Bronchogenic carcinoma: incidence of metastasis to normal sized lymph nodes// Thorax.-1995. Vol.50. — P. 1267−1269
- Bastarrika G., Garcia-Velloso MJ., Lozano MD. Early lung cancer detection using spiral computed tomography and positron emission tomography.// Am J Respir Crit Care Med.- 2005- Vol. 171. № 12.- P. 1378−83.
- Beekman F., van der Have F. The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. // Eur J .Nucl Med Mol Imaging. -2007.-Vol. 34.-№ 2.-P. 151−161.
- Berry J.D., Cook G.J., Positron emission tomography in oncology.// Br Med Bull. 2006.
- Birim O., Kappetein AP., van Klaveren RJ., Bogers AJ. Prognostic factors in non-small cell lung cancer surgery.// Eur J Surg Oncol. 2006.- Vol. 32. — № 1.- P.12−23.
- Bittner R.C., Felix R. Magnetic resonance (MR) imaging of the chest: state-of-the-art // Europ Respir J. 1998. — Vol. 11. — P. 1392−1404.
- Blodgett TM., Meltzer CC., Townsend DW. PET/CT: Form and Function.// Radiology. -.2007. Vol. 242. — № 2. — P. 360−85.
- Bogot NR., Shaham D. Semi-invasive and invasive procedures for the diagnosis and staging of lung cancer. II. Bronchoscopic and surgical procedures. // Radiol Clin North Am. 2000. — Vol.38. — P.535−544.
- Bolwig T.G., Haunso S., Hove J.D. et al. Positron emission tomography. A new measurement method for imaging of regional and biochemical parameters //Ugeskr Laeger. 1994, — Vol.156. — № 43. — P. 6341−6347.
- Bragg D.G. The diagnosis and staging of primary lung cancer// Ann.Thorac.Onc. -1994 Vol.32 — P. 1−14
- Bruzzi JF., Munden RF. PET/CT imaging of lung cancer.// J Thorac Imaging. 2006. — Vol.21. — № 2. — P. 123−36.
- Bury T., Baretto A., Daenen F., et al. Fluorine-18 deoxyglucose positron emission tomography for detection of bone metastasis in patiets witn NSLC.// Eur J Nucl Med. 1998. — Vol. 25. — P. 1244−1247.
- Bury T., Barreto A., Daenen F., Barthelemy N., Ghaye B., et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. // Eur J Nucl Med. -1998. Vol. 25. — P. 1244 — 1247.
- Bury T., Dowlati A., Paulus P., Hustinx R., et al. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.// Eur J Nucl Med. 1996. — Vol. 23. — № 2. — P. 204 — 206.
- Cerfolio RJ., Ojha B., Bryant AS., et al. The role of FDG-PET scan in staging patients with non-small cell carcinoma. // Ann Thorac Surg. 2003. -Vol.76. — P. 861−866.
- Chen DL., Dehdashti F. Advances in positron emission tomographic imaging of lung cancer.// Proc Am Thorac Soc. 2005.
- Chung JH., Cho KJ., Lee SS., Baek HJ., Park JH., Cheon GJ., Choi CW., Lim SM. Overexpression of Gluti in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging. // J Nucl Med.- 2004. Vol. 45. — № 6. — P. 999−1003.
- Clavo A.C., Brown R.S., Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. // J Nucl Med. 1995. — Vol. 36. -P. 1625−1632.
- Coleman R.E. Value of FDG PET scanning in management of lung cancer. //Lancet. 2002.- Vol. 359.-P. 1361−1362.
- Coleman R.E. Clinical PET in Oncology.//Clin Positron Imaging. 1998.
- Dales RE., Stark RM., Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. // Am Rev Respir Dis.- 1990. Vol.141- P.1096−1101.
- Demura Y., Tsuchida T., Ishizaki T., et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. // J Nucl Med. 2003. — Vol.44. — P. 540−548.
- Disdier C., Varela G., Sanchez de Cos J., et al. Usefulness of transbronchial punction and mediastinoscopy in mediastinal nodal staging of non-microcytic bronchogenic carcinoma. Preliminary study. // Arch Bron-coneumol. 1998. — Vol. 34. — P. 237−244.
- Diva F., Oliveira A., Barroso A., Conde S., Parente B. Positron emission tomography: Indications in lung cancer A prospective experience.// Rev Port Pneumol. — 2005. — Vol. 11. — P. 12 — 13.
- Dunagan D., Chin R., McCain TW., et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung can-cer.//Chest. 2001. — Vol.119. — P. 333−339.
- Dunagan D., Chin R., McCain TW., et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancers/Chest.-2001.-Vol. 119.-P. 333−339
- Dwamena BA., Sonnad SS., Angobaldo JO., et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. // Radiology. 1999. — Vol.213. — P. 530−536.
- Dwamena BA., Sonnad SS., Angobaldo JO., et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT.// Radiology. 1999. — Vol. 213. — P. 530−536.
- Engel H., Steinert H., Buck A., Berthold T. et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. //J Nucl Med. -1996.-Vol. 37.-P. 441−446.
- Erasmus JJ., Connolly JE., McAdams HP. Et al. Solitary pulmonary nodes: Morphological evaluation for differentiation of benign and malignant lesions. // Radiographics. 2000. — Vol.20. — P.43−58.
- Erasmus JJ., Patz EF., McAdams HP., Zmurray JG., Herndon J., Coleman RE., et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR.- 1997.-Vol. 168.-P. 1357−1360.
- Eschmann SM., Friedel G., Paulsen F., et al. Impact of staging with (18)F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors.// Eur J Nucl Med Mol. 2007. — Vol. 34.- № l.-P. 54−59.
- Eschmann SM., Friedel G., Paulsen F., et al. Repeat (18)F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer.//Lung Cancer. 2007 — Vol. 55.- № 2. — P. 165−71.
- Fanti S., Franchi R., Battista G. et al. PET and PET-CT. State of the art and future prospects.// Radiol Med (Torino). 2005. — Vol. 110. — P. 1−15.
- Fernandes G., Sucena M., Lombardia E. et al. Non small cell lung cancer -comparison between clinical and pathological staging // Rev Port Pneumol.-2006. Vol. 12. — № 4. — P. 337−57
- Ferray D., Mirkovich N., Albain K. Multimodality therapy for stage III non-small cell lung cancer // J. Clin. Oncol. 2005.- Vol. 23. — P. 3257−3269.
- Fischer BM., Mortensen J. The future in diagnosis and staging of lung cancer: positron emission tomography. // Respiration. 2006. -Vol. 73. — № 3.- P. 267−276.
- Fischer BM., Mortensen J., Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review.// Lancet Oncol. 2001- Vol.2. — P. 659−666.
- Fogelman I., Cook G., Israel O., et al. Positron emission tomography and bone metastases. // Semin Nucl Med. 2005. — Vol. 35. — № 2. — P. 13 542.
- Ford E.C., Kinahan P.E., Hanlon L., Alessio A. et al. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.//
- MedPhys.-2006. Vol. 33. -№ 11.-P. :4280−4288.
- Freixinet Gilart J., Garcia PG., De Castro FR., et al. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma. // Ann Thorac Surg. 2000. — Vol.70. — P.1641−1643.
- Fritscher-Ravens A., Sriram PV., Bobrowski C., et al. Mediastinal lympha-denopathy in patients with or without previous malignancy: EUS-FNAbased differential cytodiagnosis in 153 patients.// Am J Gastroenterol. 2000 — Vol. 95. — P. 2278−2284.
- Giacone G. State of the art in systemic treatment of lung cancer.// Eur J Cancer. 2001. — Vol. 37.- P. 99−114.
- Ginsberg R. Role of surgery in treatment of stage I and II lung cancer// proc. ASCO. 2001. — P.460−464.
- Ginsberg RJ., Rice TW., Goldberg M, et al. Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe. // J Thorac Cardiovasc Surg. 1987. — Vol.94. — P. 673−678.
- Goldstraw P., Kurzer M., Edwards D. Preoperative staging of lung cancer: accuracy of computed tomography versus mediastinoscopy. // Thorax. 1983-Vol. 38.-P. 10−15.
- Gontier E., Vaylet F., Bonardel G. et al. 18-FI)G positon emission tomography and distal metastasis from lung cancer. // Rev Pneumol Clin. 2005. — Vol. 61.- P. 248−57.
- Gorospe Sarasua L., Echeveste Aizpurua J., Raman S. et al. Positronemission tomography/computed tomography: artifacts and pitfalls in cancer patients. // Radiologia. 2006. — Vol. 48. — № 4. — P. 189−204.
- Gould MK., Maclean CC., Kuschner WG., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. //JAMA. 2001- Vol. 285. — № 7. — P. 914 — 924.
- Gould MK., Maclean CC., Kuschner WG., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. // JAMA. 2001. — Vol. 285. — P. 914−924.
- Graeter TP., Hellwig D., Hoffmann K., et al. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. //Ann Thorac Surg. -2003.-Vol. 75.-P.231−236.
- Graeter TP., Hellwig D., Hoffmann K., et al. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. //Ann Thorac Surg. -2003.
- Gupta NC., Graeber GM., Tamim WJ. Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer. // Clin Lung Cancer. 2001. — Vol. 3. — № 1. — P. 59−64.
- Gupta NC., Tamim WJ., Graeber GM., et al. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. // Chest. 2001.- Vol. 120. — P. 521 — 527.
- Haberkorn U., Schoenberg SO. Imaging of lung cancer with CT, MRT and PET. // Lung Cancer. 2001 — Vol. 34. — P. 13−23.
- Hagge RJ., Coleman RE. Positron emission tomography: lung cancer.// Semin Roentgenol. 2002. — Vol. 37. — № 2. — P. 110−117.
- Harrow EM., Oldenburg FA Jr., Lingenfelter MS., et al. Transbronchial-needle aspiration in clinical practice. A five-year experience. // Chest. -1989. Vol. 96 — P. 1268−1272.
- Haubold-Reuter B., Haldemann R, Amann F., et al. Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium.//
- Schweiz Med Wochenschr. 1992. — Vol. 122. — P. 14−21.
- Hellwig D., Ukena D., Paulsen F., et al. Meta-analysis of the efficacy of positron emission tomography with F-18- fluorodeoxyglucose.// Pneumologie.- 2001. Vol. 55. — P. 367−377.
- Hierholzer J., Luo L., Bittner R.C. et al. MRI and CT in the differential diagnosis of pleural disease. // Chest. 2000. — Vol. 118. — P. 604−609.
- Higashi K., Ueda Y., Arisaka Y., Sakuma T. et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer .//J Nucl Med. 2002.
- Holland J.F., Bast Jr D.C., Morton et al. Cancer Medicine.4th edition.-Williams&Willlcins.- 1997.
- Hong R., Halama J., Bova D., Sethi A. et al. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.// In J Radiat Oncol Biol Phys. 2007. — Vol. 67. — P. 720−726.
- Hustinx R., Paulus P., Jacquet N., et al. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. // Ann Oncol. 1998. — Vol. 9. — № 4. — P. 397−401.
- Ide M. Cancer screening with FDG-PET.// Q J Nucl Med Mol Imaging. 2006. — Vol. 50. — № 1. — P. 23 — 27.
- Igai H., Gotoh M., Yokomise H. Computed tomography (CT) and positron emission tomography with 18 °F.fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer. // Eur J Cardiothorac Surg. 2006.
- Jiao X., Magistrelli P., Goldstraw P. The value of cervical mediastinoscopy combined with anterior mediastinotomy in the peroperative evaluation of bronchogenic carcinoma of the left upper lobe. // Eur J Cardiothorac Surg. 1997.- Vol. 11. P. 450−454.
- Kamiyoshihara M., Kawashima O., Ishikawa S., et al. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer.// J Cardiovasc Surg. (Torino). 2001. — Vol.42. — P. 119−124.
- Kernstine KH, Stanford W, Mullan BF., et al. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma. // Ann Thorac Surg. 1999. — Vol.68. — P. 1022−1028
- Kernstine KH., Mclaughlin KA., Menda Y., Rossi NP., Kahn DJ., Bushnell DL., et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? //Ann Thorac Surg. -2002. Vol. 73. — № 2. — P. 394 — 401.
- Kondo D., Imaizumi M., Abe T, et al. Endoscopic ultrasound examination for mediastinal lymph node metastases of lung cancer.// Chest. -1990.-Vol. 98 P. 586−593.
- Kubota K., Matsuzawa T., Fujiwara T. et al. Differential diagnosis of lung tumor with PET//J Nucl Med. 1990. — Vol.12. — P. 1927−1932
- Kumar R., Xiu Y., Yu JQ., Takalkar A. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.// J Nucl Med. 2004. — Vol. 45.-№ 12.-P. 2058 -2062.
- Lai P., Bomanji J.B., Mahmood S. et al. Detection of tumour thrombus by 18F-FDG-PET/CT imaging.// Eur J Cancer Prev. 2007 — Vol. 16. — № 1. — P.:90 — 94.
- Laissy JP., Gay-Depassier P., Soyer P., et al. Enlarged mediastinal lymph nodes in bronchogenic carcinoma: assessment with dynamic contras-tenhanced MR imaging. // Radiology. 1994 — Vol. 191. — P. 263−267.
- Langer C.J. Mind Your Elders: Therapeutic Implications of Epidermal Growth Factor Receptor Inhibition in Older Patients With Advanced Non-Small-Cell Lung Cancer // J. Clin. Oncol. 2007.
- Larsen SS., Krasnik M., Vilmann P., et al. Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management. //Thorax. 2002. — Vol. 57- P.98−103.
- Lau CL., Harpole DH Jr., Patz E., et al. Staging techniques for lung cancer.//
- Chest Surg Clin N Am. 2000. — Vol. 10. — № 4. — P. 781−801.
- Lauenstein T.C., Goehde S.C., Herborn C.U., et al. Whole-body MR imaging: evaluation of patients for metastases. // Radiology. 2004. — Vol. 233.-№ l.-P. 139- 148.
- Lowe VJ., DeLong DM, Hoffman JM et al. Optimum scanning protocol for FDG PET evaluation of pulmonary malignancy// J Nucl Med. -1995.-Vol.36. P. 883−887.
- Mac Manus M.P., Hicks R.J. PET scanning in lung cancer: current status and future directions.// Semin Surg Oncol. 2003. — Vol. 21. — № 3. -P. 149- 155.
- Maisey M., Jeffery P. Clinical applications of positron emission tomography.//
- Br J Clin Pract. 1991. — Vol.45. — № 4. — P. 265 — 272.
- Mandelkern M., Raines J. Positron emission tomography in cancer research and treatment.// Technol Cancer Res Treat. 2002. — Vol. 1. — № 6 .-P. 423−431.
- Markos J., Mullan B.P., Hillman D.R. et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. //Amer Rev Respir Dis. 1989. — Vol.139. — P.902−910.
- Marom EM., McAdams HP., Erasmus JJ., et al. Staging nonsmall cell lung cancer with whole-body PET.// Radiology. 1999. — Vol. 212. — P. 803−809.
- Marsden P., Sutcliffe-Goulden J. Principles and technology of PET scanning.//
- Nucl Med Commun. 2000. — Vol. 21. — P. 221−224.
- Martini N., Bains MS., Burt ME., et al. Incidence of local reccurence and second primary tumors in resected stage I lung cancer// J Thorc Cardio-vasc Surg.-Vol. 109.-P. 120−129.
- Meikle S. R, Bailey D.L., Hooper P.K., Eberl S., et al. Simultaneous emission and transmission measurements for attenuation correction in whole-body PET.//J Nucl Med. 1995. — Vol. 36. — № 9.-P. 1680−1688.
- Mentzer SJ, Swanson SJ, DeCamp MM., et al. Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer.// Chest. 1997. Vol.112. — P. 239−241.
- Messa C., Bettinardi V., Picchio M., Pelosi E. et al. PET/CT in diagnostic oncology.// Q J Nucl Med Mol Imaging. 2004. — Vol. 48. — № 2. -P. 66−75.
- Misciasci T. Noninvasive staging of lung cancer. // Rays. 2004. -Vol. 29.-№ 4.-P. 363−371.
- Misciasci T. Noninvasive staging of lung cancer.// Rays. 2004. — Vol.29. — № 4. — P. 363−71.
- Naruke T., Goya T., Tsuchiya R. et al. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. //Ann. Thorac. Surg. 1988. — Vol. 46. — № 6. — P. 603 — 610.
- Naruke T., Goya T., Tsuchiya R., Suemasu K. et al. Prognosis and survival in resected lung carcinoma based on the new international staging system.//
- J Thorac Cardiovasc Surg. 1988. — Vol. 96. — № 3. — P. 440−447.
- Naruke T., Tsuchiya R., Kondo H. et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.// Ann Thorac Surg. 2001. — Vol. 71. -№ 6. -P. 1757−1758.
- Nguyen XC., Lee WW., Chung J., et al. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: Correlations and prognostic values.// Eur J Radiol 2007.
- Nolop K.B., Rhodes C.G., Brudin L.H. et al. Glucose utilization in vivo by human pulmonary neoplasms. // Cancer. 1987. — Vol. 60. — P. 11.
- Nomori H., Watanabe K., Ohtsuka M., Naruke T., et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. // Lung Cancer. 2004 -Vol. 45. — P. 19−27.
- Ohtsuka T., Nomori H., Watanabe K. Prognostic significance of (18)F.fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. // Cancer. 2006.
- Ohtsuka T., Nomori H., Watanabe K., et al. Prognostic significance of (18)F.fluorodeoxyglucose uptake on positron emission tomography inpatients with pathologic stage I lung adenocarcinoma.// Cancer. 2006. 1. Vol. 15.-P. 2468−2473.
- Okamoto H., Watanabe K., Nagatomo A., et al. Endobronchial ultrasonography for mediastinal and hilar lymph node metastases of lung cancer.//Chest. 2002. — Vol. 121 — P. 1498−1506.
- Okazumi S., Isono K., Enomoto K. et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.// J Nucl Med. 1992. — Vol.33. — № 3. -P. 333−339.
- Ozgul MA., Uysal MA., Kadakal F., et al. Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer. // Tuberk Toraks.- 2006. Vol. 54. — № 3. -P. 229−234.
- Palko A. Imaging diagnosis of lung cancer // Magy Onlcol. 2006 -Vol. 50.-№ 3.-P. 217−221.
- Paltz E.F., Lowe VJ et al. Focal pulmonary abnormalities: evaluation with PET-scanning// Radiology. 1993. — Vol.188. — P. 487−490.
- Pass H., Mitchel J., Johnson D., et al. Lung cancer.- Raven. 1996. -P.982.
- Patel V., Shrager J.B. Which patients with stage III non-small cell lung cancer should undergo surgical resection // Oncol. 2005. — Vol. 10. -P. 335−344.
- Patelli M., Agli LL., Poletti V., et al. Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non-small cell lung cancer. // Ann Thorac Surg. 2002. — Vol. 73. — P. 407−411.
- Pepe G., Rossetti C., Sironi S., Landoni C., et al. Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study.//
- Nucl Med Commun-2005.-Vol. 26. № 9. — P.831−837.
- Perrotin C., Lemeunier P., Grahek D., et al. Molina Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumor.// Rev Mai Respir. 2005. — Vol. 22. — № 4. — P. 579−85.
- Perrotin C., Lemeunier P., Grahek D., Molina T. Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors. // Rev Mai Respir. 2005 — Vol.22. — № 4. — P. 579−85
- Peterson JJ., Kransdorf MJ., O’Connor MI. Diagnosis of occult bone metastases: positron emission tomography. // Clin Orthop Relat Res. -2003. Vol. 415. — P. 120 — 128.
- Pieterman RM., Van Putten JWG., Meuzelaar JJ., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography.// N Engl J Med. 2000 — Vol.343. — P.254 — 261.
- Pieterman RM., Van Putten JWG., Meuzelaar JJ., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. // N Engl J Med. 2000. — Vol.343. — P. 254−261.
- Pieterman RM., Van Putten JWG., Meuzelaar JJ., et al. Preoperative staging of non-small cell lung cancer with positron emission tomography. // New Engl J Med. 2000. — Vol. 393. — P. 254−261.
- Porrello A, Cardelli P, Spugnini EP. Pet models in cancer research: general principles.// J Exp Clin Cancer Res.- 2004. Vol. 23. — № 2. -P.181−193.
- Porte H., Roumilhac D., Eraldi L., et al. The role of mediastinoscopy in the diagnosis of mediastinal lymphadenopathy. // Eur J Cardiothorac Surg.- 1998.-Vol.13.-P. 196−199.
- Quint L.E. Preoperative staging of NSLC: imaging methods//Am J Roengenol.-1995. Vol.164. — P. 1349−1359
- Robinson L., Wagner H., Ruckdeschel J.C. Treatment of stage IIIA non-small cell lung cancer// Chest. 2003. — Vol. 123, — P. 202−220.
- Rosell R, Gomez-Codina J, Camps C. et al. A randominazed trial compairing preoperative chemotherapy plus surgery alone in patients with non-small lung cancer. //N Engl J Med 1994. — Vol.330. — P.153−158.
- Salathe M., Soler M., Bolliger CT., et al. Transbronchial needle aspiration in routine fiberoptic bronchoscopy. // Respiration. 1992.- Vol. 59.-P. 5−8.
- Saunders CA., Dussek JE., O’Doherty MJ., et al. Evaluation of fluorine- 18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. // Ann Thorac Surg. 1999. — Vol. 67. -P. 790−797.
- Schenk DA., Bower JH., Bryan CL., et al. Transbronchial needle aspiration staging of bronchogenic carcinoma.// Am Rev Respir Dis. 1986. -Vol.134.-P. 146−148.
- Schirrmeister H., Glatting G., Hetzel J., Nussle K., et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.// J Nucl Med. 2001. -Vol.42.-№ 12.-P. 1800- 1804.
- Schirrmeister H., Guhlmann A., Eisner K., et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18 °F PET. // J. Nucl Med 1999. — Vol. 40. — № 10. — P. 1623 — 1629.
- Schrevens L., Vansteenkiste J., Deneffe G., et al. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer.// Oncologist. 2004. — Vol.9.- № 6. — P. 633−43.
- Shannon JJ., Bude RO., Orens JB., et al. Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy.// Am J Respir Crit Care Med. 1996. — Vol.153. — P. 1424−1430.
- Shin V., Bhargava P., Brown J., et al. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.// Med Sei Monit. 2006.
- Staples CA., Muller NL., Miller RR., et al. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. //Radiology. 1988. Vol.167. — P. 367−372.
- Steinert HC. PET in lung cancer. // Chang Gung Med J. 2005. -Vol.28.-№ 5.-P. 296−305.
- Steinert HC., Hauser M., Allemann F., Engel H., et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. // Radiology. 1997.
- Stewart LA, Pignon JP. Chemotherapy in non-small lung cancer// Br Med J. 1995.-Vol.311.-P.899−909.
- Stokkel MP., Bakker PF., Heine R., et al. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.// Nucl Med Commun.- 1999. Vol. 20. — № 11. — P. 1001−1007.
- Takamochi K., Yoshida J., Murakami K., et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.// Lung Cancer. 2005.
- Talbot JN., Kerrou K., Grahek D., Balogova S, et al. PET in primary pulmonary or pleural cancer. // Presse Med. 2006. — Vol. 35. — P. 1387 -1400.
- Tan BB., Flaherty KR., Kazerooni EA., et al. The solitary pulmonary nodule.// Chest.- 2003. Vol.123. — P. 89−96.
- Townsend D.W., Beyer T., Meitzer C.C., Dachille M.A. et al. The EC AT ART Scanner for Positron Emission Tomography. // Clin Positron Imaging. 1999. — Vol. 2. -№ 1. — P. 17−30.
- Tsunezuka Y., Shimizu Y., Tanaka N., et al. Positron Emission Tomography in Relation to Noguchi’s Classification for Diagnosis of Peripheral Non-Small-Cell Lung Cancer 2 cm or Less in Size. // World J Surg -2007.
- Tsunezuka Y., Shimizu Y., Tanaka N., Takayanagi T., Kawano M. Positron Emission Tomography in Relation to Noguchi’s Classification for Diagnosis of Peripheral Non-Small-Cell Lung Cancer 2 cm or Less in Size. //World J Surg.- 2007.
- Valk PE., Pounds TR., Hopkins DM., et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. //Ann Thorac Surg.- 1995. Vol.60-P. 1573−1581.
- Van den Hoff J. Principles of quantitative positron emission tomography.//
- Amino Acids. 2005. — Vol. 29. — № 4. — P. 341 — 353.
- Vansteenkiste IF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. // Eur Respir J. 2001. — Vol. 17. — P. 802−820.
- Vansteenkiste JF., Stroobants SG., De Leyn PR., et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. // J Clin Oncol. 1998. -Vol.16-P. 2142−2149.
- Veit P., Ruehm S., Kuehl H. et al. Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology.// Eur J Radiol. 2006. — Vol. 58. — № 3. — P. 383 — 389.
- Volkow N.D., Mullani N.A., Bendriem B. Positron emission tomography instrumentation: an overview.// Am J Physiol Imaging. 1988. -Vol. 3.-№ 3.-P. 142−145.
- Wahl RL, Quint L.E., Meyer C.R., et al. Staging of mediastinal non-small lung cancer with PET, CT and fusion images// Radiology. 1994. -Vol.191.-P. 371−379.
- Wahl RL., Quint LE., Greenough RL., Meyer CR., White RL, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. // Radiology. 1994.-Vol. 191.-№ 2.-P. 371−377.
- Wallace MB., Silvestri GA., Sahai AV., et al. Endoscopic ultra-soundguided fine needle aspiration for staging patients with carcinoma of the lung. //Ann Thorac Surg. 2001. — Vol.72. — P. 1861−1867.
- Wang Y., Chiu E, Rosenberg J., Gambhir S.S. Standardized Uptake Value Atlas: Characterization of Physiological 2-Deoxy-2-(18)F.fluoro-D: -glucose Uptake in Normal Tissues.//Mol Imaging Biol. 2007.
- Watanuki S. Attenuation correction methods in PET and PET/CT: basic principles and validity.// Nippon Hoshasen Gijutsu Gakkai Zasshi. -2006. Vol. 62. — № 6. — P. 797−803.
- Webb WR., Gatsonis C., Zerhouni EA., et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma. Report of the Radiologic Diagnostic Oncology Group. // Radiology. 1991. — Vol. 178. — P. 705 713.
- Wiersema MJ., Vilmann P., Giovannini M., et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment.//Gastroenterology. 1997-Vol. 112.-P. 1087−1095.
- Yano T., Yokoyama H., Inoue., et al. The first site of reccurence after complete resection in NSLC.// J Thorc Cardiovasc Surg. 1994. — Vol. 108.-P. 680−683.
- Yasufuku K., Nakajima T., Motoori K., Sekine Y., Shibuya K., Hiroshima K. Fujisawa Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.// Chest. 2006. — Vol. 130. — № 3. — P. 710 — 718.